Intuitive Surgical, Inc. (ISRG) Stake Decreased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,026 shares of the medical equipment provider’s stock after selling 957 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Intuitive Surgical were worth $2,525,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Edgewood Management LLC boosted its position in shares of Intuitive Surgical by 200.7% in the 3rd quarter. Edgewood Management LLC now owns 2,898,113 shares of the medical equipment provider’s stock worth $1,010,359,000 after buying an additional 1,934,382 shares in the last quarter. Koch Industries Inc. boosted its position in shares of Intuitive Surgical by 202,917.0% in the 2nd quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock worth $1,387,000 after buying an additional 1,387,952 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Intuitive Surgical by 7,931.4% in the 2nd quarter. Janus Henderson Group PLC now owns 412,170 shares of the medical equipment provider’s stock worth $385,532,000 after buying an additional 407,038 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its position in shares of Intuitive Surgical by 214.2% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 386,037 shares of the medical equipment provider’s stock worth $140,881,000 after buying an additional 263,157 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in shares of Intuitive Surgical by 289.1% in the 4th quarter. Bank of Montreal Can now owns 158,747 shares of the medical equipment provider’s stock worth $57,933,000 after buying an additional 117,951 shares in the last quarter. 32.82% of the stock is currently owned by institutional investors and hedge funds.

In other Intuitive Surgical news, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $400.00, for a total value of $1,200,000.00. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $3,955,200. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Mark J. Rubash sold 6,000 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $395.95, for a total transaction of $2,375,700.00. Following the completion of the transaction, the director now owns 5,453 shares in the company, valued at $2,159,115.35. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 55,944 shares of company stock worth $21,432,971. 2.20% of the stock is owned by insiders.

Intuitive Surgical, Inc. (NASDAQ ISRG) opened at $433.23 on Friday. The stock has a market cap of $48,670.00, a PE ratio of 55.97, a price-to-earnings-growth ratio of 5.38 and a beta of 0.47. Intuitive Surgical, Inc. has a 1-year low of $217.19 and a 1-year high of $436.57.

Several equities research analysts recently commented on the stock. Leerink Swann reiterated an “outperform” rating and issued a $475.00 price objective (up from $390.00) on shares of Intuitive Surgical in a research report on Thursday. BidaskClub upgraded shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 11th. Barclays reiterated an “overweight” rating and issued a $465.00 price objective on shares of Intuitive Surgical in a research report on Thursday, January 11th. Vetr upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 price objective on the stock in a research report on Monday, January 8th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $410.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $368.71.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/01/20/intuitive-surgical-inc-isrg-stake-decreased-by-wealth-enhancement-advisory-services-llc.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply